TeselaGen Biotechnology Inc – Trademark Portfolio
Entity Type: 03
TeselaGen Biotechnology Inc holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include TESELAGEN, MAKE LIFE BETTER, and SYNTHETIC EVOLUTION. The owner is based in San Francisco, CA.
1501 Mariposa St, Suite 312
San Francisco, CA 94107
Showing of trademarks Trademarks
Trademark Classifications
TeselaGen Biotechnology Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does TeselaGen Biotechnology Inc have?
TeselaGen Biotechnology Inc has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.
What trademark classes does TeselaGen Biotechnology Inc file in?
TeselaGen Biotechnology Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TeselaGen Biotechnology Inc's most well-known trademarks?
TeselaGen Biotechnology Inc's registered trademark portfolio includes well-known marks such as TESELAGEN, MAKE LIFE BETTER, and SYNTHETIC EVOLUTION. These are among 3 currently registered trademarks in the portfolio.
What is TeselaGen Biotechnology Inc's trademark registration success rate?
TeselaGen Biotechnology Inc has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.